AtaiBeckley
ATAI----
AtaiBeckley (ATAI)
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the Uni...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
AtaiBeckley Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$9.5933.53%
Forecast & RatingHold
14analysts
- Strong buy21.43%
- Buy0.00%
- Hold78.57%
- Sell0.00%
- Strong sell0.00%
News
- Simplywall · 17 hours ago
Is AtaiBeckley (ATAI) A Bargain On Eli Lilly’s Takeover Deal?
- PR Newswire · Jul 21 at 01:50 PM
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders?
- MSN · Jul 19 at 11:11 PM
Why did ATAI, PANW, TRV stocks surge to 52-week highs last week?
- Market Beat · Jul 18 at 04:28 AM
Gallacher Capital Management LLC Decreases Stake in Eli Lilly and Company $LLY
- rttnews · Jul 18 at 12:22 AM
Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data
- MorningStar · Jul 17 at 02:15 PM
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
